FDA approval of Roche, Boehringer drugs for idiopathic pulmonary fibrosis is a big step forward

The U.S. Food and Drug Administration has approved two drugs Esbriet and Ofev for the treatment of idiopathic pulmonary fibrosis (IPF). The drugs slow down the progression of the disease.